Logo image of BMEZ

BLACKROCK HLTH SCI TRM TR II (BMEZ) Stock Price, Quote, News and Overview

NYSE:BMEZ - New York Stock Exchange, Inc. - US09260E1055 - Currency: USD

14.46  -0.02 (-0.14%)

Fundamental Rating

2

Overall BMEZ gets a fundamental rating of 2 out of 10. We evaluated BMEZ against 0 industry peers in the Unkown industry. BMEZ has a bad profitability rating. Also its financial health evaluation is rather negative. BMEZ has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

BMEZ had positive earnings in the past year.
BMEZ had a positive operating cash flow in the past year.
In multiple years BMEZ reported negative net income over the last 5 years.
Of the past 5 years BMEZ 4 years had a positive operating cash flow.
BMEZ Yearly Net Income VS EBIT VS OCF VS FCFBMEZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 1B -1B -2B

1.2 Ratios

Industry RankSector Rank
ROA 1.23%
ROE 1.26%
ROIC 0.15%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BMEZ Yearly ROA, ROE, ROICBMEZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 20 -20

1.3 Margins

Industry RankSector Rank
OM 12.13%
PM (TTM) 78.05%
GM 21.95%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BMEZ Yearly Profit, Operating, Gross MarginsBMEZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 5K -5K 10K 15K

More info and screens

3

2. Health

2.1 Basic Checks

There is no outstanding debt for BMEZ. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BMEZ Yearly Shares OutstandingBMEZ Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 20M 40M 60M 80M 100M
BMEZ Yearly Total Debt VS Total AssetsBMEZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 1B 2B 3B

2.2 Solvency

An Altman-Z score of 11.53 indicates that BMEZ is not in any danger for bankruptcy at the moment.
BMEZ has a debt to FCF ratio of 0.00. This is a very positive value and a sign of high solvency as it would only need 0.00 years to pay back of all of its debts.
A Debt/Equity ratio of 0.00 indicates that BMEZ is not too dependend on debt financing.
Although BMEZ does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 11.53
ROIC/WACCN/A
WACCN/A
BMEZ Yearly LT Debt VS Equity VS FCFBMEZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 1B -1B 2B -2B 3B

2.3 Liquidity

A Current Ratio of 0.66 indicates that BMEZ may have some problems paying its short term obligations.
A Quick Ratio of 0.66 indicates that BMEZ may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.66
Quick Ratio 0.66
BMEZ Yearly Current Assets VS Current LiabilitesBMEZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 5M 10M 15M 20M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for BMEZ have decreased strongly by -65.08% in the last year.
Looking at the last year, BMEZ shows a very strong growth in Revenue. The Revenue has grown by 133.91%.
BMEZ shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 66.80% yearly.
EPS 1Y (TTM)-65.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%88%
Revenue 1Y (TTM)133.91%
Revenue growth 3Y66.8%
Revenue growth 5YN/A
Sales Q2Q%187.82%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BMEZ Yearly Revenue VS EstimatesBMEZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 65.73, the valuation of BMEZ can be described as expensive.
The average S&P500 Price/Earnings ratio is at 27.45. BMEZ is valued rather expensively when compared to this.
Industry RankSector Rank
PE 65.73
Fwd PE N/A
BMEZ Price Earnings VS Forward Price EarningsBMEZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 3.38
EV/EBITDA N/A
BMEZ Per share dataBMEZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 14.61%, BMEZ is a good candidate for dividend investing.
BMEZ's Dividend Yield is rather good when compared to the S&P500 average which is at 2.42.
Industry RankSector Rank
Dividend Yield 14.61%

5.2 History

BMEZ has been paying a dividend for over 5 years, so it has already some track record.
The dividend of BMEZ decreased recently.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
BMEZ Yearly Dividends per shareBMEZ Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

741.67% of the earnings are spent on dividend by BMEZ. This is not a sustainable payout ratio.
DP741.67%
EPS Next 2YN/A
EPS Next 3YN/A
BMEZ Yearly Income VS Free CF VS DividendBMEZ Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 0 1B -1B -2B
BMEZ Dividend Payout.BMEZ Dividend Payout, showing the Payout Ratio.BMEZ Dividend Payout.PayoutRetained Earnings

More info and screens

BLACKROCK HLTH SCI TRM TR II

NYSE:BMEZ (7/3/2025, 7:05:21 PM)

14.46

-0.02 (-0.14%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)09-01 2025-09-01
Inst Owners35.85%
Inst Owner Change-2.22%
Ins OwnersN/A
Ins Owner Change0%
Market Cap903.75M
Analysts0
Price TargetN/A
Short Float %0.39%
Short Ratio1.02
Dividend
Industry RankSector Rank
Dividend Yield 14.61%
Yearly Dividend1.61
Dividend Growth(5Y)N/A
DP741.67%
Div Incr Years1
Div Non Decr Years1
Ex-Date06-13 2025-06-13 (0.16902)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 65.73
Fwd PE N/A
P/S 29.39
P/FCF 3.38
P/OCF 3.38
P/B 0.47
P/tB 0.47
EV/EBITDA N/A
EPS(TTM)0.22
EY1.52%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)4.27
FCFY29.54%
OCF(TTM)4.27
OCFY29.54%
SpS0.49
BVpS30.51
TBVpS30.51
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.23%
ROE 1.26%
ROCE 0.19%
ROIC 0.15%
ROICexc 0.15%
ROICexgc 0.15%
OM 12.13%
PM (TTM) 78.05%
GM 21.95%
FCFM 868.29%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion N/A
Profit Quality 1112.5%
Current Ratio 0.66
Quick Ratio 0.66
Altman-Z 11.53
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-65.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%88%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)133.91%
Revenue growth 3Y66.8%
Revenue growth 5YN/A
Sales Q2Q%187.82%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y129.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y18.67%
FCF growth 3Y12.07%
FCF growth 5YN/A
OCF growth 1Y18.67%
OCF growth 3Y12.07%
OCF growth 5YN/A